X-domain of peptide synthetases recruits oxygenases crucial for glycopeptide biosynthesis K Haslinger, M Peschke, C Brieke, E Maximowitsch, MJ Cryle Nature 521 (7550), 105-109, 2015 | 186 | 2015 |
MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters BR Terlouw, K Blin, JC Navarro-Muñoz, NE Avalon, MG Chevrette, ... Nucleic acids research 51 (D1), D603-D610, 2023 | 119 | 2023 |
The structure of a transient complex of a nonribosomal peptide synthetase and a cytochrome P450 monooxygenase K Haslinger, C Brieke, S Uhlmann, L Sieverling, RD Süssmuth, MJ Cryle Angewandte Chemie International Edition 53 (32), 8518-8522, 2014 | 88* | 2014 |
Cytochrome P450 OxyBtei catalyzes the first phenolic coupling step in teicoplanin biosynthesis K Haslinger, E Maximowitsch, C Brieke, A Koch, MJ Cryle ChemBioChem 15 (18), 2719-2728, 2014 | 57 | 2014 |
Sequential in vitro cyclization by cytochrome P450 enzymes of glycopeptide antibiotic precursors bearing the X‐domain from nonribosomal peptide biosynthesis C Brieke, M Peschke, K Haslinger, MJ Cryle Angewandte Chemie 127 (52), 15941-15945, 2015 | 56 | 2015 |
Regulation of the P450 oxygenation cascade involved in glycopeptide antibiotic biosynthesis M Peschke, K Haslinger, C Brieke, J Reinstein, MJ Cryle Journal of the American Chemical Society 138 (21), 6746-6753, 2016 | 53 | 2016 |
Rapid access to glycopeptide antibiotic precursor peptides coupled with cytochrome P450-mediated catalysis: towards a biomimetic synthesis of glycopeptide antibiotics C Brieke, V Kratzig, K Haslinger, A Winkler, MJ Cryle Organic & biomolecular chemistry 13 (7), 2012-2021, 2015 | 37 | 2015 |
Structure of the terminal PCP domain of the non‐ribosomal peptide synthetase in teicoplanin biosynthesis K Haslinger, C Redfield, MJ Cryle Proteins: Structure, Function, and Bioinformatics 83 (4), 711-721, 2015 | 31 | 2015 |
Heterologous caffeic acid biosynthesis in Escherichia coli is affected by choice of tyrosine ammonia lyase and redox partners for bacterial Cytochrome P450 K Haslinger, KLJ Prather Microbial cell factories 19, 1-12, 2020 | 29 | 2020 |
Current State and Future Directions of Genetics and Genomics of Endophytic Fungi for Bioprospecting Efforts R Sagita, WJ Quax, K Haslinger Frontiers in Bioengineering and Biotechnology 9, 10.3389/fbioe.2021.649906, 2021 | 24 | 2021 |
Structure of OxyAtei: completing our picture of the glycopeptide antibiotic producing Cytochrome P450 cascade K Haslinger, MJ Cryle FEBS letters 590 (4), 571-581, 2016 | 19 | 2016 |
Rapid in vitro prototyping of O-methyltransferases for pathway applications in Escherichia coli K Haslinger, T Hackl, KLJ Prather Cell Chemical Biology 28 (6), 876-886. e4, 2021 | 11 | 2021 |
Natural combinatorial genetics and prolific polyamine production enable siderophore diversification in Serratia plymuthica S Cleto, K Haslinger, KL Prather, TK Lu BMC Biology 19 (1), 46, 2021 | 11 | 2021 |
Oxidative transformations of amino acids and peptides catalysed by Cytochromes P450 MJ Cryle, C Brieke, K Haslinger | 8 | 2013 |
Artemisinin-type drugs in tumor cell death: mechanisms, combination treatment with biologics and nanoparticle delivery X Zhou, F Suo, K Haslinger, WJ Quax Pharmaceutics 14 (2), 395, 2022 | 7 | 2022 |
Striving for sustainable biosynthesis: discovery, diversification, and production of antimicrobial drugs in Escherichia coli R Iacovelli, N Sokolova, K Haslinger Biochemical Society Transactions 50 (5), 1315-1328, 2022 | 4 | 2022 |
Structural Characterization and Extended Substrate Scope Analysis of Two Mg2+‐Dependent O‐Methyltransferases from Bacteria** N Sokolova, L Zhang, S Deravi, R Oerlemans, MR Groves, K Haslinger ChemBioChem 24 (9), e202300076, 2023 | 3 | 2023 |
Engineering a plant polyketide synthase for the biosynthesis of methylated flavonoids B Peng, L Zhang, S He, R Oerlemans, WJ Quax, MR Groves, K Haslinger Journal of Agricultural and Food Chemistry 72 (1), 529-539, 2023 | 2 | 2023 |
Artemisinin-type drugs in tumor cell death: mechanisms, combination treatment with biologics and nanoparticle delivery. Pharmaceutics 2022; 14: 395 X Zhou, F Suo, K Haslinger, WJ Quax s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | 2 | 2022 |
Pathway towards renewable chemicals K Haslinger, KLJ Prather Nature Microbiology 2 (12), 1580-1581, 2017 | 2 | 2017 |